Articles with public access mandates - Brigitte SolaLearn more
Available somewhere: 21
The double dealing of cyclin D1
G Tchakarska, B Sola
Cell cycle 19 (2), 163-178, 2020
Mandates: Swiss Cancer League
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells
S Body, A Esteve-Arenys, H Miloudi, C Recasens-Zorzo, G Tchakarska, ...
Scientific reports 7 (1), 13946, 2017
Mandates: European Commission, Government of Spain, Swiss Cancer League
Resistance to the proteasome inhibitors: Lessons from multiple myeloma and mantle cell lymphoma
M Gonzalez-Santamarta, G Quinet, D Reyes-Garau, B Sola, G Roué, ...
Proteostasis and Disease: From Basic Mechanisms to Clinics, 153-174, 2020
Mandates: European Commission, Government of Spain, Swiss Cancer League
Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism
B Sola, M Poirot, P De Medina, S Bustany, V Marsaud, S Silvente-Poirot, ...
Oncotarget 4 (6), 911, 2013
Mandates: National Institute of Health and Medical Research, France
Antitumoral Activity of Lenalidomide in In Vitro and In Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes
A Moros, S Bustany, J Cahu, I Saborit-Villarroya, A Martínez, D Colomer, ...
Clinical Cancer Research 20 (2), 393-403, 2014
Mandates: Government of Spain, Swiss Cancer League
Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells
M Caillot, J Bourgeais, H Dakik, É Costé, NM Mazure, É Lelièvre, ...
Oncogenesis 9 (7), 68, 2020
Mandates: National Institute of Health and Medical Research, France, Swiss Cancer League
XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-Cell Lymphoma
H Miloudi, É Bohers, F Guillonneau, A Taly, VC Gibouin, PJ Viailly, ...
Cancers 12 (10), 2829, 2020
Mandates: Agence Nationale de la Recherche, Swiss Cancer League
Cyclin K and cyclin D1b are oncogenic in myeloma cells
V Marsaud, G Tchakarska, G Andrieux, JM Liu, D Dembele, B Jost, ...
Molecular cancer 9, 1-19, 2010
Mandates: National Institute of Health and Medical Research, France
Management of drug resistance in mantle cell lymphoma
G Roué, B Sola
Cancers 12 (6), 1565, 2020
Mandates: Government of Spain, Swiss Cancer League
ROS overproduction sensitises myeloma cells to bortezomib-induced apoptosis and alleviates tumour microenvironment-mediated cell resistance
M Caillot, F Zylbersztejn, E Maitre, J Bourgeais, O Hérault, B Sola
Cells 9 (11), 2357, 2020
Mandates: Swiss Cancer League
Targeting reactive oxygen species metabolism to induce myeloma cell death
M Caillot, H Dakik, F Mazurier, B Sola
Cancers 13 (10), 2411, 2021
Mandates: Swiss Cancer League
Cyclin D1 regulates p27Kip1 stability in B cells
S Bustany, G Tchakarska, B Sola
Cellular signalling 23 (1), 171-179, 2011
Mandates: US National Institutes of Health
Deazaneplanocin a is a promising drug to kill multiple myeloma cells in their niche
J Gaudichon, F Milano, J Cahu, L DaCosta, AC Martens, JM Renoir, ...
PloS one 9 (9), e107009, 2014
Mandates: Swiss Cancer League
HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress
C Coudre, J Alani, W Ritchie, V Marsaud, B Sola, J Cahu
Cell Cycle 15 (16), 2174-2182, 2016
Mandates: Swiss Cancer League
Constitutive activation of p62/Sequestosome-1-mediated proteaphagy regulates proteolysis and impairs cell death in bortezomib-resistant mantle cell lymphoma
G Quinet, W Xolalpa, D Reyes-Garau, N Profitós-Pelejà, M Azkargorta, ...
Cancers 14 (4), 923, 2022
Mandates: European Commission, Government of Spain, Swiss Cancer League
Pure antiestrogen‐induced G1‐arrest in myeloma cells results from the reduced kinase activity of cyclin D3/CDK6 complexes whereas apoptosis is mediated by endoplasmic reticulum …
J Gauduchon, A Seguin, V Marsaud, D Clay, JM Renoir, B Sola
International journal of cancer 122 (9), 2130-2141, 2008
Mandates: National Institute of Health and Medical Research, France
Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma
M Caillot, H Miloudi, A Taly, N Profitós‐Pelejà, JC Santos, ML Ribeiro, ...
Molecular Oncology 17 (12), 2546-2564, 2023
Mandates: Swiss Cancer League
A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress
K Ben Younes, S Body, É Costé, PJ Viailly, H Miloudi, C Coudre, F Jardin, ...
BMC cancer 17, 1-12, 2017
Mandates: Swiss Cancer League
A mouse model of disseminated mantle cell lymphoma highlights a lack of activity of estrogen receptor β agonists toward tumor burden
S Body, A Esteve-Arenys, C Recasens-Zorzo, X Troussard, G Roué, ...
Leukemia & lymphoma 59 (7), 1726-1729, 2018
Mandates: Government of Spain, Swiss Cancer League
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma
M Durand, V Cabaud Gibouin, L Duplomb, L Salmi, M Caillot, B Sola, ...
Journal of Experimental & Clinical Cancer Research 43 (1), 148, 2024
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
Publication and funding information is determined automatically by a computer program